A tool developed in Singapore that takes less than 2 minutes to tell if a person has a major eye problem has just been approved for sale in Europe. The system, called Selena+, was developed jointly by SERI and the NUS School of Computing. It can tell from a photograph of the person's eye whether he has diabetic retinopathy, glaucoma or age-related macular degeneration with a greater than 90 percent accuracy. SingHealth holds the licence on behalf of Seri and NUS, and it has licensed it to local start-up EyRIS, which obtained the European Union approval, known as a CE mark.
Prof Wong Tien Yin, Medical Director, SNEC; DGCEO, SingHealth, was quoted in the story in his capacity as Seri Chairman and said that the CE mark will now allow a Singaporean company to provide this product in Europe. The article also noted that EyRIS signed an MOU with the Singapore Optometric Association last Thursday on the use of Selena+, and the partnership will provide even wider access to primary eye care for Singaporeans. Dr Gavin Tan, Head of Ocular Imaging, SNEC, was also quoted in the story.